Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)
主要な著者: | Hillmen, P, Pettitt, A, Schuh, A, Milligan, D, Bowles, K, Bareford, D, Riaz, J, Follows, G, Rule, S, Wallis, J, Gribben, J, Noble, R, Pocock, C, Lisby, S, Carey, J, Gupta, I, Chang, C, McKeown, A |
---|---|
フォーマット: | Journal article |
出版事項: |
2014
|
類似資料
-
Azathioprine, cyclophosphamide and chlorambucil.
著者:: Luqmani, R, 等
出版事項: (1990) -
UK experience of Ofatumumab in refractory B-CLL
著者:: Varghese, A, 等
出版事項: (2011) -
Chlorambucil-Induced Acute Interstitial Pneumonitis
著者:: Hammad Shafqat, 等
出版事項: (2014-01-01) -
Rapid desensitization for chlorambucil drug fever
著者:: E Weber, 等
出版事項: (2007-07-01) -
Ofatumumab retreatment and maintenance in patients with fludarabine-refractory CLL.
著者:: Osterborg, A, 等
出版事項: (2012)